by Waylon Wright | Aug 23, 2017
Pearl Pathways announces the hiring of Mark Slisz as a Senior Advisor serving biopharmaceutical, medical device, and diagnostic life science companies. Slisz brings over 35 years of experience in the pharmaceutical industry to Pearl Pathways. His experience includes...
by Waylon Wright | Aug 21, 2017
The U.S. Food and Drug Administration (FDA) provides various ways to speed new drugs and medical devices to market. Even though some contest that FDA is too slow when it comes to product approvals, data suggests otherwise. However, in spite of quicker approval...
by Waylon Wright | Jul 11, 2017
Commissioner Scott Gottlieb promised to eliminate the backlog of orphan drug designation requests following a June 20th Senate hearing on President Donald Trump’s FY2018 budget request for the US Food and Drug Administration (FDA). Gottlieb stated that he will soon...
by Waylon Wright | Jul 10, 2017
The BioCrossroads New Venture Competition, an early stage business competition designed to encourage entrepreneurial activity of Indiana life sciences and health information technologies, is now accepting applications at www.biocrossroads.com. Since 2012, the...
by Waylon Wright | Jul 10, 2017
A Guide to the New Pearl Pathways Website Welcome to the redesigned Pearl Pathways website! The site contains a lot of new content to explore, but this “guide” details some of the biggest additions and changes. A few motivations guided the development...